As the founder and chief executive officer of Ambrose Cell Therapy in Tampa, Florida, Matthew (Matt) Feshbach strives to treat patients with life-threatening and debilitating disorders who have exhausted other health care options. Under Matthew Feshbach’s leadership, Ambrose provides experimental ADRC (adipose-derived stem and regenerative cells) therapies in compliance with the federal Right to Try Act of 2017.

Before establishing this organization in 2018, Matthew Feshbach served six years with Okyanos Cell Therapy in Freeport, Bahamas. He established Okyanos with his his brothers Joe in 2011. Approximately 85% of the patients reported sustained improvement in symptoms, function and quality of life.

In addition to his accomplishments in the stem cell field, Mr. Feshbach founded MLF Investments since 2001. After generating exceptional profits using short-only hedge fund strategies in the 1980s, he has taken a long-only investment approach with a steady focus on rising shareholder value.

In his free time, Matt Feshbach enjoys activities such as swimming, walking, and yoga. A wine connoisseur, he also likes to cook simple gourmet meals.